Transfusion Dependent Beta-Thalassemia Clinical Trials in Tianjin, Tianjin Municipality
3 recruitingTianjin, Tianjin Municipality, China
Showing 1–3 of 3 trials
Recruiting
Not Applicable
Safety and Efficacy of the Lentiviral Vector in Gene Therapy of Beta-thalassemia Patients
Transfusion Dependent Beta-Thalassemia
Institute of Hematology & Blood Diseases Hospital, China3 enrolled1 locationNCT06219239
Recruiting
Phase 1Phase 2
Β-Thalassemia Treatment with KL003 Cell Injection
Transfusion Dependent Beta-Thalassemia
Kanglin Biotechnology (Hangzhou) Co., Ltd.41 enrolled2 locationsNCT06280378
Recruiting
Growth and Development-related Outcomes in Children With Transfusion-dependent Beta-thalassemia After Gene Therapy
Gene TherapyTransfusion Dependent Beta-Thalassemia
Institute of Hematology & Blood Diseases Hospital, China100 enrolled1 locationNCT05991336